PALB2 and breast cancer: The prevalence and clinical outcome of germline mutations in the BRCA1/2 and/or PALB2 genes in breast cancer patients in different ethnic groups, including populations from Turkey,26 Lebanon,27 Japan,28 Mexico,29 China,30, 31, 32 etc, have been widely reported recently.